Cargando…
Mapping Canadian Data Assets to Generate Real-World Evidence: Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s RWE Data Working Group
Canadian provinces routinely collect patient-level data for administrative purposes. These real-world data (RWD) can be used to generate real-world evidence (RWE) to inform clinical care and healthcare policy. The CanREValue Collaboration is developing a framework for the use of RWE in cancer drug f...
Autores principales: | Dai, Wei Fang, de Oliveira, Claire, Blommaert, Scott, Pataky, Reka E., Tran, David, Aurangzeb, Zeb, Kendell, Cynthia, Folkins, Chris, Somayaji, Chandy, Dowden, Jeff, Cheung, Winson, Strumpf, Erin, Beca, Jaclyn M., McClure, Carol, Urquhart, Robin, McDonald, James Ted, Alvi, Riaz, Turner, Donna, Peacock, Stuart, Denburg, Avram, Mercer, Rebecca E., Muñoz, Caroline, Parmar, Ambica, Tadrous, Mina, Takhar, Pam, Chan, Kelvin K. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947246/ https://www.ncbi.nlm.nih.gov/pubmed/35323365 http://dx.doi.org/10.3390/curroncol29030165 |
Ejemplares similares
-
Engaging Patients in the Canadian Real-World Evidence for Value in Cancer Drugs (CanREValue) Initiative: Processes and Lessons Learned
por: Evans, William K., et al.
Publicado: (2022) -
Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration
por: Parmar, Ambica, et al.
Publicado: (2023) -
Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s Reassessment and Uptake Working Group
por: Dai, Wei Fang, et al.
Publicado: (2021) -
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
por: Chan, Kelvin, et al.
Publicado: (2020) -
Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise
por: Dai, Wei Fang, et al.
Publicado: (2021)